ArticleClinical and translational medicine2022

S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3-mediated programmed death-ligand 1 expression in colorectal cancer.

Hye-Young Min et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.